RSV and Influenza Update

We continue to see endemic levels of RSV. Our percentages have been running over 30% for the past few weeks. We are also seeing quite a bit of Influenza (both A and B this year are going strong). Our Influenza numbers are greater than they were last year at this time and our Influenza B is especially high. This is important when considering antiviral administration as the older antivirals (Amantadine and Rimantidine) do not cover Influenza B. Of course the vaccine has both A and B components and we will know a bit later in the season about the effectiveness of this year's vaccine selection.